Ying Gong

机构：Sun Yat-sen University, Fudan University, Maastricht University Medical Centre, Maastricht University, Nanfang Hospital, Cell Technology (China), Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Southern Medical University · ORCID：0000-0001-5987-5344

发表论文 30 篇 · 总被引 747 次 · h-index 13

代表论文

• Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy (2021 · Journal of Hematology & Oncology · 被引 381)
• Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor (2020 · Molecular Therapy — Methods & Clinical Development · 被引 56)
• The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice (2018 · Diabetologia · 被引 38)
• NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody (2024 · Molecular Therapy · 被引 33)
• Exosomes in Autoimmune Diseases: A Review of Mechanisms and Diagnostic Applications (2025 · Clinical Reviews in Allergy & Immunology · 被引 21)
• Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity (2021 · Cancers · 被引 18)